Showing 1 - 10 of 952
This report provides an assessment of the Department of Health's (DOH) three drug provision programs, i.e., Botika ng Barangay (BnB), Botika ng Bayan (BNB), and the P100 Treatment Pack (P100). (a) The BnB program expanded its distribution network rapidly in the past decade, contributing to...
Persistent link: https://www.econbiz.de/10011421242
There is a growing emphasis on the role of trade in health services (telehealth, health tourism and retirement, investments and deployment of medical professionals) in easing fiscal constraints, generating jobs and income, improving infrastructure and financing, and upgrading the capacities of...
Persistent link: https://www.econbiz.de/10011429822
Persistent link: https://www.econbiz.de/10014374380
Persistent link: https://www.econbiz.de/10014374515
Despite the decline in the discovery of new chemical entities for pharmaceutical use, there is a significant proliferation of patents on products and processes that cover minor, incremental innovations. A study conducted in five developing countries - Argentina, Brazil, Colombia, India and South...
Persistent link: https://www.econbiz.de/10012490815
We study the choice of drug for the treatment of high blood pressure (hypertension) in Sweden between 1988-1994. During this time period calcium antagonists and ACE-inhibitors increased their market shares at the expense of the older drugs diuretics and beta-blockers. We use a prescription micro...
Persistent link: https://www.econbiz.de/10010281210
Drugs and medicines account for about half of the total medical out-of-pocket expenses of households. This share of drugs to total medical expenses is much higher for the poor than the rich. Thus, affordability of medicines is an important issue in poverty reduction. Recent efforts to improve...
Persistent link: https://www.econbiz.de/10011421202
Persistent link: https://www.econbiz.de/10012490821
Persistent link: https://www.econbiz.de/10012490830